definiens: means ( i ) the treatment of Parkinson ’s Disease [ * * ] of any [ * * ], and ( ii ) the treatment of off episodes in advanced Parkinson ’s Disease [ * * ] of an y [ * * ] . ” [ * * ] = CERTAIN CONFIDENTIAL INFORMATION OMITTED ( b ) Section 11.1 is deleted in its entirety and replace d with the following : “ The Parties acknowledge and agree that BPL has the primary right ( but not the obligation ) to supply P roducts under this Agreement . Subject to Clause 11.2 and pr ovided BPL has agreed or elected to supply the same, for the Initial Term and thereafter until such time as USWM loses its exclusivity to Joint IP under Clauses 4 . 6.1, 4.6.2 or 4.6.3, unless either Party has terminated this Agre ement in accordance with its terms, USWM shall purc hase all of its requirements of : ( i ) the Apokyn [ * * ] Pen Pro duct ; ( ii ) the [ * * ] ; ( iii ) Peripherals ( or any repl acement peripherals where any agreed supplier resolves no l onger to supply the same to BPL for the Territory ) and ( iv ) any other Product arising from any Joint New Developmen t, exclusively from BPL, and BPL shall use commerci ally reasonable efforts to supply same to USWM, on the t erms and conditions provided herein . If BPL elects not to supply any Product, then the payments due to BPL he reunder for such Product shall be determined in acc ordance with Clause 13.2.1 . Where BPL is supplying, payment s shall be calculated in accordance with Clause 12